Bridgewater Associates’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.65M | Sell |
47,780
-54,291
| -53% | -$3.91M | 0.02% | 492 |
|
|
2025
Q4 | $6.52M | Buy |
+102,071
| New | +$6.29M | 0.02% | 458 |
|
|
2025
Q3 | – | Sell |
-9,779
| Closed | -$730K | – | 1029 |
|
|
2025
Q2 | $730K | Sell |
9,779
-120,926
| -93% | -$9.5M | ﹤0.01% | 494 |
|
|
2025
Q1 | $11.5M | Buy |
130,705
+22,115
| +20% | +$2.09M | 0.05% | 238 |
|
|
2024
Q4 | $9.92M | Sell |
108,590
-9,655
| -8% | -$990K | 0.05% | 258 |
|
|
2024
Q3 | $13.2M | Buy |
118,245
+28,328
| +32% | +$2.83M | 0.08% | 222 |
|
|
2024
Q2 | $8.81M | Sell |
89,917
-17,638
| -16% | -$1.75M | 0.05% | 267 |
|
|
2024
Q1 | $10.8M | Buy |
107,555
+12,329
| +13% | +$1.08M | 0.05% | 244 |
|
|
2023
Q4 | $8.55M | Buy |
95,226
+55,460
| +139% | +$4.42M | 0.05% | 267 |
|
|
2023
Q3 | $3.05M | Buy |
39,766
+20,596
| +107% | +$1.71M | 0.02% | 436 |
|
|
2023
Q2 | $1.6M | Buy |
+19,170
| New | +$1.56M | 0.01% | 503 |
|
|
2022
Q3 | – | Sell |
-122,413
| Closed | -$11M | – | 912 |
|
|
2022
Q2 | $11M | Buy |
122,413
+43,907
| +56% | +$4.55M | 0.05% | 311 |
|
|
2022
Q1 | $8.8M | Buy |
+78,506
| New | +$9.2M | 0.04% | 327 |
|
|
2021
Q3 | – | Sell |
-39,780
| Closed | -$4.64M | – | 716 |
|
|
2021
Q2 | $4.64M | Buy |
+39,780
| New | +$4.78M | 0.03% | 344 |
|
|
2021
Q1 | – | Sell |
-12,232
| Closed | -$1.23M | – | 498 |
|
|
2020
Q4 | $1.23M | Sell |
12,232
-1,285
| -10% | -$119K | 0.01% | 360 |
|
|
2020
Q3 | $1.06M | Buy |
13,517
+10,420
| +336% | +$785K | 0.01% | 336 |
|
|
2020
Q2 | $216K | Buy |
+3,097
| New | +$195K | ﹤0.01% | 370 |
|
|
2020
Q1 | – | Sell |
-7,272
| Closed | -$576K | – | 466 |
|
|
2019
Q4 | $576K | Sell |
7,272
-139,649
| -95% | -$10.7M | 0.01% | 398 |
|
|
2019
Q3 | $10.8M | Sell |
146,921
-151,260
| -51% | -$10.9M | 0.1% | 96 |
|
|
2019
Q2 | $23.2M | Sell |
298,181
-301,843
| -50% | -$22.9M | 0.18% | 48 |
|
|
2019
Q1 | $45.5M | Sell |
600,024
-24,531
| -4% | -$1.95M | 0.28% | 21 |
|
|
2018
Q4 | $45.7M | Buy |
+624,555
| New | +$49.8M | 0.42% | 26 |
|
|
2017
Q3 | – | Sell |
-33,231
| Closed | -$2.79M | – | 317 |
|
|
2017
Q2 | $2.79M | Buy |
+33,231
| New | +$2.68M | 0.03% | 146 |
|
|
2016
Q4 | – | Sell |
-53,800
| Closed | -$3.64M | – | 294 |
|
|
2016
Q3 | $3.64M | Sell |
53,800
-85,000
| -61% | -$5.7M | 0.04% | 149 |
|
|
2016
Q2 | $9.43M | Buy |
138,800
+73,283
| +112% | +$5.39M | 0.12% | 74 |
|
|
2016
Q1 | $4.73M | Sell |
65,517
-72,052
| -52% | -$4.72M | 0.06% | 124 |
|
|
2015
Q4 | $9.29M | Sell |
137,569
-243,469
| -64% | -$17M | 0.12% | 73 |
|
|
2015
Q3 | $24.7M | Buy |
381,038
+335,500
| +737% | +$24.8M | 0.33% | 15 |
|
|
2015
Q2 | $3.73M | Sell |
45,538
-181,000
| -80% | -$14M | 0.03% | 146 |
|
|
2015
Q1 | $15.7M | Sell |
226,538
-75,248
| -25% | -$5.43M | 0.12% | 23 |
|
|
2014
Q4 | $22.9M | Buy |
301,786
+243,659
| +419% | +$19.3M | 0.18% | 11 |
|
|
2014
Q3 | $4.7M | Buy |
58,127
+12,000
| +26% | +$1M | 0.04% | 102 |
|
|
2014
Q2 | $4.03M | Buy |
46,127
+34,140
| +285% | +$2.97M | 0.03% | 130 |
|
|
2014
Q1 | $1.03M | Sell |
11,987
-36,400
| -75% | -$2.98M | 0.01% | 238 |
|
|
2013
Q4 | $3.9M | Sell |
48,387
-5,900
| -11% | -$458K | 0.03% | 133 |
|
|
2013
Q3 | $4.23M | Buy |
+54,287
| New | +$4.18M | 0.04% | 107 |
|
Other funds holding EMN
VPM
VCM
Bridgewater Associates's EMN Position: Q1 2026 in Review
Bridgewater Associates reduced its Eastman Chemical (EMN) stake by 53% in Q1 2026, selling an estimated $3.91M and leaving 47,780 shares worth $3.65M. The position accounts for 0.02% of the portfolio, ranked #492.
Bridgewater Associates first reported a position in EMN in Q3 2013 and has held it in 36 quarters since. The position peaked at $45.7M in Q4 2018. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.
- Bridgewater Associates held 47,780 shares of Eastman Chemical worth $3.65M as of Q1 2026.
- Bridgewater Associates sold 54,291 Eastman Chemical shares in Q1 2026, an estimated $3.91M.
- Eastman Chemical made up 0.02% of Bridgewater Associates's portfolio in Q1 2026, its #492 holding.
- Bridgewater Associates first reported a position in Eastman Chemical in Q3 2013 and has held it in 36 quarters since.
- Bridgewater Associates's Eastman Chemical position peaked at $45.7M in Q4 2018.
- 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.
Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.